Researchers at the Yale School of Medicine are launching the PRISMS study

Introducing our Community Engagement Board (CEB) Spotlight Series! The NAPS Consortium partners with incredible individuals in our community. Meet the Voices of NAPS: Bob Norman 🌟

We're excited to announce that our manuscript, "The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients with REM Sleep Behavior Disorder," has been published in Neurology.

Did you know REM sleep behavior disorder (RBD)—acting out dreams—may be an early sign of Parkinson’s disease or dementia with Lewy bodies?

Researchers are working to identify biomarkers that could help detect these conditions earlier and open the door to prevention.

Congratulations to Dr. Wolfgang Singer, NAPS Investigator at Mayo Clinic, on being awarded the 2026 Irwin Schatz Award for outstanding contributions to autonomic disorders.

We're thrilled to share that Dr. Bradley Boeve, one of our NAPS Principal Investigators, has co-authored a brand-new book: "The Behavioral Neurology of Dementia (3rd Edition)."

You're invited to the Fifth Annual COBRAS Symposium at Washington University in St. Louis on Thursday, May 7, 2026.

Thank you to everyone who joined us on April 7 for the NAPS Consortium Updates Webinar! 🧠✨ Watch the full webinar with the latest updates from the NAPS Consortium, including new data, recent progress, and ongoing initiatives.

This webinar will highlight the latest updates from the NAPS Consortium, including new data, recent progress, and ongoing initiatives. It’s a great opportunity for researchers, clinicians, and community members to stay informed and connected.

Does sleep apnea increase Parkinson's risk?

A major new study led by NAPS investigator Dr. Lee Neilson, based on more than 11 million veteran health records, found that having obstructive sleep apnea in midlife is linked to a higher risk of developing Parkinson’s disease later on.

At the National Academy of Neuropsychology Conference in Los Angeles, Dr. Youssef Khattab, Research Coordinator at OHSU, presented new NAPS data titled “Quantifying cognitive change across one year in RBD: Initial follow-up of the NAPS Consortium study.

Better and faster science in synucleinopathies can bring us closer to neuroprotective clinical trials.

In a recent issue of Current Neurology and Neuroscience Reports, Drs. Lee Neilson and Miranda Lim, NAPS Investigators from Oregon Health Sciences University, review cutting-edge science in REM Sleep Behavior Disorder (RBD) and synucleinopathies.

Could we use wearable trackers to screen for RBD? 💭

Dr. Emmanuel During and colleagues reported a fascinating case in JAMA Neurology.

Dr. Albert “Gus” Davis joined experts in sleep, epilepsy, and circadian medicine for an engaging session exploring how these systems intertwine to influence neurological health at ANA2025.

Dr. Chengjie Xiong, leader of the NAPS Data & Statistical Management Core, shared groundbreaking findings at the International Parkinson and Movement Disorder Society Congress.

NAPS hosted the 3rd Annual Industry Roundtable concurrent with the Movement Disorders Society Congress in Honolulu, bringing together leaders from across academia and industry with one shared goal – preparing for neuroprotective treatment trials for synucleinopathies.

Earlier this year, president Joe Biden recognized Miranda Lim, M.D., Ph.D. (OHSU) with the Presidential Early Career Award for Scientists and Engineers (PECASE) – the nation’s highest honor for early-career researchers.

Dr. Lim is one of only 14 recipients from the U.S. Department of Veterans Affairs and among about 400 awardees nationwide.

At the 2025 World Sleep Congress in Singapore, our investigators highlighted the powerful intersections of sleep, epilepsy, and circadian health.

New research led by NAPS Co-Principal Investigator Dr. Ronald Postuma, sheds light on the earliest signs of synucleinopathies like Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy.

Dr. Lynn Marie Trotti has been named the new Director of the Emory Sleep Center, succeeding Dr. Nancy Collop, who retires after 15 years of transformative leadership.